TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 309 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $162,000 | -13.4% | 11,523 | -11.7% | 0.03% | +58.8% |
| Q1 2022 | $187,000 | -56.6% | 13,052 | -44.9% | 0.02% | -66.7% |
| Q4 2020 | $431,000 | -50.8% | 23,680 | -51.8% | 0.05% | -57.1% |
| Q3 2020 | $876,000 | -37.7% | 49,081 | -31.1% | 0.12% | -25.6% |
| Q4 2019 | $1,405,000 | +138.9% | 71,217 | +114.3% | 0.16% | +107.8% |
| Q2 2019 | $588,000 | -25.9% | 33,232 | -14.8% | 0.08% | -30.6% |
| Q1 2019 | $794,000 | – | 38,991 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |